(-)-epigallocatechin 3-gallate multiple interactions ISO CAV2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CAV2 mRNA CTD PMID:22079256 (S)-nicotine decreases expression ISO Cav2 (Mus musculus) 6480464 Nicotine results in decreased expression of CAV2 mRNA CTD PMID:33640489 1,2-dichloroethane affects expression ISO Cav2 (Mus musculus) 6480464 ethylene dichloride affects the expression of CAV2 mRNA CTD PMID:28960355 17beta-estradiol multiple interactions ISO CAV2 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CAV2 mRNA and [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CAV2 mRNA CTD PMID:19619570 and PMID:20823114 17beta-estradiol decreases expression ISO CAV2 (Homo sapiens) 6480464 Estradiol results in decreased expression of CAV2 mRNA CTD PMID:19619570 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Cav2 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO CAV2 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CAV2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cav2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CAV2 mRNA CTD PMID:28238261 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CAV2 mRNA CTD PMID:26232522 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO CAV2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CAV2 mRNA CTD PMID:19619570 and PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cav2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CAV2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CAV2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CAV2 mRNA CTD PMID:22298810 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cav2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CAV2 mRNA CTD PMID:19770486 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of CAV2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of CAV2 mRNA CTD PMID:21346803 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO CAV2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CAV2 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO Cav2 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CAV2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO Cav2 (Mus musculus) 6480464 bisphenol S results in increased expression of CAV2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO Cav2 (Mus musculus) 6480464 Fenretinide results in decreased expression of CAV2 mRNA CTD PMID:28973697 5-fluorouracil decreases expression ISO CAV2 (Homo sapiens) 6480464 Fluorouracil results in decreased expression of CAV2 mRNA CTD PMID:16510598 5-fluorouracil increases expression ISO CAV2 (Homo sapiens) 6480464 Fluorouracil results in increased expression of CAV2 mRNA CTD PMID:24737281 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CAV2 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CAV2 mRNA CTD PMID:25825206 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CAV2 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO Cav2 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of CAV2 mRNA CTD PMID:19770486 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CAV2 mRNA CTD PMID:33354967 all-trans-retinoic acid increases expression ISO CAV2 (Homo sapiens) 6480464 Tretinoin results in increased expression of CAV2 mRNA CTD PMID:15894607 all-trans-retinoic acid multiple interactions ISO CAV2 (Homo sapiens) 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of CAV2 mRNA CTD PMID:15894607 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CAV2 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO CAV2 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of CAV2 mRNA CTD PMID:24449571 arsenous acid multiple interactions ISO CAV2 (Homo sapiens) 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CAV2 mRNA CTD PMID:15894607 arsenous acid decreases expression ISO CAV2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of CAV2 mRNA CTD PMID:15725085 arsenous acid increases expression ISO CAV2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CAV2 mRNA CTD PMID:15761015 benzo[a]pyrene decreases methylation ISO CAV2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of CAV2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO Cav2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CAV2 mRNA CTD PMID:32417428 bis(2-ethylhexyl) phthalate increases expression ISO CAV2 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of CAV2 mRNA CTD PMID:31163220 bisphenol A increases expression ISO Cav2 (Mus musculus) 6480464 bisphenol A results in increased expression of CAV2 mRNA CTD PMID:26063408 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CAV2 mRNA CTD PMID:32145629 and PMID:33296240 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CAV2 mRNA CTD PMID:30816183 bisphenol A decreases expression ISO CAV2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of CAV2 mRNA CTD PMID:29275510 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CAV2 mRNA CTD PMID:25181051 Bisphenol A diglycidyl ether multiple interactions ISO CAV2 (Homo sapiens) 6480464 2 and 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone results in increased expression of CAV2 protein] CTD PMID:16806087 Bisphenol B increases expression ISO CAV2 (Homo sapiens) 6480464 bisphenol B results in increased expression of CAV2 protein CTD PMID:34186270 bisphenol F multiple interactions ISO CAV2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CAV2 mRNA CTD PMID:28628672 bisphenol F increases expression ISO CAV2 (Homo sapiens) 6480464 bisphenol F results in increased expression of CAV2 protein CTD PMID:34186270 bisphenol F increases expression ISO Cav2 (Mus musculus) 6480464 bisphenol F results in increased expression of CAV2 mRNA CTD PMID:30951980 bucladesine multiple interactions ISO CAV2 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CAV2 mRNA CTD PMID:20823114 butan-1-ol multiple interactions ISO CAV2 (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CAV2 mRNA CTD PMID:29432896 butanal decreases expression ISO CAV2 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of CAV2 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO Cav2 (Mus musculus) 6480464 Cadmium promotes the reaction [HMOX1 protein binds to CAV2 protein] CTD PMID:14658758 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CAV2 mRNA CTD PMID:25993096 cadmium dichloride increases expression ISO CAV2 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of CAV2 mRNA CTD PMID:26472689 carbamazepine affects expression ISO CAV2 (Homo sapiens) 6480464 Carbamazepine affects the expression of CAV2 mRNA CTD PMID:25979313 carbon nanotube affects expression ISO Cav2 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of CAV2 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO Cav2 (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of CAV2 mRNA CTD PMID:25554681 chloropicrin decreases expression ISO CAV2 (Homo sapiens) 6480464 chloropicrin results in decreased expression of CAV2 mRNA CTD PMID:28476498 chloropicrin affects expression ISO CAV2 (Homo sapiens) 6480464 chloropicrin affects the expression of CAV2 mRNA CTD PMID:26352163 chromium(6+) decreases expression ISO CAV2 (Homo sapiens) 6480464 chromium hexavalent ion results in decreased expression of CAV2 mRNA CTD PMID:30690063 cisplatin multiple interactions ISO CAV2 (Homo sapiens) 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of CAV2 mRNA CTD PMID:30871063 cobalt dichloride decreases expression ISO CAV2 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of CAV2 mRNA CTD PMID:19320972 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of CAV2 mRNA CTD PMID:24386269 crocidolite asbestos decreases expression ISO Cav2 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of CAV2 mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CAV2 mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO CAV2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CAV2 mRNA CTD PMID:20106945 and PMID:27989131 dexamethasone increases expression ISO CAV2 (Homo sapiens) 6480464 Dexamethasone results in increased expression of CAV2 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO CAV2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CAV2 mRNA CTD PMID:28628672 diarsenic trioxide decreases expression ISO CAV2 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of CAV2 mRNA CTD PMID:15725085 diarsenic trioxide increases expression ISO CAV2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CAV2 mRNA CTD PMID:15761015 diarsenic trioxide multiple interactions ISO CAV2 (Homo sapiens) 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CAV2 mRNA CTD PMID:15894607 dimethylarsinic acid decreases expression ISO CAV2 (Homo sapiens) 6480464 Cacodylic Acid results in decreased expression of CAV2 mRNA CTD PMID:17720352 dimethylarsinous acid decreases expression ISO CAV2 (Homo sapiens) 6480464 dimethylarsinous acid results in decreased expression of CAV2 mRNA CTD PMID:23487506 dioxygen multiple interactions EXP 6480464 [Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV2 protein and Simvastatin inhibits the reaction [[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV2 protein] CTD PMID:16698853 disodium selenite decreases expression ISO Cav2 (Mus musculus) 6480464 Sodium Selenite results in decreased expression of CAV2 mRNA CTD PMID:23274088 diuron decreases expression EXP 6480464 Diuron results in decreased expression of CAV2 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO CAV2 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO CAV2 (Homo sapiens) 6480464 Doxorubicin results in increased expression of CAV2 mRNA CTD PMID:29803840 entinostat increases expression ISO CAV2 (Homo sapiens) 6480464 entinostat results in increased expression of CAV2 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO Cav2 (Mus musculus) 6480464 epoxiconazole results in decreased expression of CAV2 mRNA CTD PMID:35436446 ethanol affects splicing ISO Cav2 (Mus musculus) 6480464 Ethanol affects the splicing of CAV2 mRNA CTD PMID:30319688 FR900359 increases phosphorylation ISO CAV2 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of CAV2 protein CTD PMID:37730182 furan decreases expression EXP 6480464 furan results in decreased expression of CAV2 mRNA CTD PMID:25539665 and PMID:26194646 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CAV2 mRNA CTD PMID:22061828 glafenine increases expression EXP 6480464 Glafenine results in increased expression of CAV2 mRNA CTD PMID:24136188 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of CAV2 mRNA CTD PMID:20621112 hexadecanoic acid multiple interactions ISO CAV2 (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of CAV2 mRNA CTD PMID:30547786 indometacin multiple interactions ISO CAV2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CAV2 mRNA CTD PMID:28628672 isobutanol multiple interactions ISO CAV2 (Homo sapiens) 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CAV2 mRNA CTD PMID:29432896 lead(0) affects expression ISO CAV2 (Homo sapiens) 6480464 Lead affects the expression of CAV2 mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions ISO CAV2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CAV2 mRNA CTD PMID:35811015 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of CAV2 mRNA CTD PMID:28801915 medroxyprogesterone acetate multiple interactions ISO CAV2 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CAV2 mRNA CTD PMID:20823114 mercury dibromide increases expression ISO CAV2 (Homo sapiens) 6480464 mercuric bromide results in increased expression of CAV2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO CAV2 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV2 mRNA CTD PMID:27188386 methotrexate increases expression ISO CAV2 (Homo sapiens) 6480464 Methotrexate results in increased expression of CAV2 mRNA CTD PMID:17379860 Methylazoxymethanol acetate increases expression EXP 6480464 Methylazoxymethanol Acetate results in increased expression of CAV2 mRNA CTD PMID:28349193 methylmercury chloride increases expression ISO CAV2 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of CAV2 mRNA CTD PMID:28001369 monocrotaline decreases expression EXP 6480464 Monocrotaline results in decreased expression of CAV2 mRNA and Monocrotaline results in decreased expression of CAV2 protein CTD PMID:24835767 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of CAV2 gene CTD PMID:33148267 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of CAV2 mRNA CTD PMID:28801915 N-nitrosodiethylamine increases expression ISO Cav2 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of CAV2 mRNA CTD PMID:24535843 nicotine decreases expression ISO Cav2 (Mus musculus) 6480464 Nicotine results in decreased expression of CAV2 mRNA CTD PMID:33640489 oleic acid multiple interactions ISO CAV2 (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of CAV2 mRNA CTD PMID:30547786 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of CAV2 mRNA CTD PMID:23439660 p-chloromercuribenzoic acid increases expression ISO CAV2 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in increased expression of CAV2 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO CAV2 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV2 mRNA CTD PMID:27188386 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of CAV2 mRNA CTD PMID:27638505 paracetamol affects expression ISO Cav2 (Mus musculus) 6480464 Acetaminophen affects the expression of CAV2 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CAV2 mRNA CTD PMID:22112502 and PMID:30723492 paraquat increases expression ISO CAV2 (Homo sapiens) 6480464 Paraquat results in increased expression of CAV2 mRNA CTD PMID:35182771 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of CAV2 mRNA CTD PMID:16221955 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of CAV2 gene CTD PMID:33148267 phenobarbital affects expression ISO Cav2 (Mus musculus) 6480464 Phenobarbital affects the expression of CAV2 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO CAV2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of CAV2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO CAV2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV2 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO CAV2 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CAV2 mRNA CTD PMID:19710929 potassium chromate multiple interactions ISO CAV2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CAV2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO CAV2 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of CAV2 mRNA CTD PMID:22079256 and PMID:22714537 quercetin decreases expression ISO Cav2 (Mus musculus) 6480464 Quercetin results in decreased expression of CAV2 protein CTD PMID:12134086 rimonabant multiple interactions ISO Cav2 (Mus musculus) 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of CAV2 mRNA] CTD PMID:19030233 rotenone multiple interactions EXP 6480464 [Rotenone co-treated with polylactic acid-polyglycolic acid copolymer] results in decreased expression of CAV2 mRNA CTD PMID:23816754 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO CAV2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CAV2 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO CAV2 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom decreases expression ISO Cav2 (Mus musculus) 6480464 Silver results in decreased expression of CAV2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Cav2 (Mus musculus) 6480464 Silver results in decreased expression of CAV2 mRNA CTD PMID:27131904 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV2 protein] CTD PMID:16698853 sodium arsenite decreases expression ISO Cav2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of CAV2 mRNA CTD PMID:16014739 sunitinib decreases expression ISO CAV2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of CAV2 mRNA CTD PMID:31533062 taurocholic acid increases secretion ISO CAV2 (Homo sapiens) 6480464 CAV2 protein results in increased secretion of Taurocholic Acid CTD PMID:14647059 temozolomide increases expression ISO CAV2 (Homo sapiens) 6480464 Temozolomide results in increased expression of CAV2 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO CAV2 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of CAV2 mRNA CTD PMID:15336504 testosterone multiple interactions ISO CAV2 (Homo sapiens) 6480464 [FSHB protein co-treated with Testosterone] results in decreased expression of CAV2 mRNA CTD PMID:18535249 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CAV2 mRNA CTD PMID:22112502 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CAV2 mRNA CTD PMID:23411599 titanium dioxide increases expression ISO Cav2 (Mus musculus) 6480464 titanium dioxide results in increased expression of CAV2 mRNA CTD PMID:23409001 titanium dioxide decreases expression ISO Cav2 (Mus musculus) 6480464 titanium dioxide results in decreased expression of CAV2 mRNA CTD PMID:23557971 triadimefon decreases expression ISO CAV2 (Homo sapiens) 6480464 triadimefon results in decreased expression of CAV2 mRNA CTD PMID:26705709 trichostatin A increases expression ISO CAV2 (Homo sapiens) 6480464 trichostatin A results in increased expression of CAV2 mRNA CTD PMID:24935251 trimellitic anhydride decreases expression ISO Cav2 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of CAV2 mRNA CTD PMID:19042947 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of CAV2 mRNA CTD PMID:30589522 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of CAV2 mRNA CTD PMID:24136188 valproic acid decreases expression ISO CAV2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CAV2 mRNA CTD PMID:29154799 valproic acid increases expression ISO CAV2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of CAV2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO CAV2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV2 mRNA CTD PMID:27188386 valproic acid increases methylation ISO CAV2 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of CAV2 gene CTD PMID:29154799 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CAV2 mRNA CTD PMID:19015723